GARCOEA ARMENTA, MARIA ELENA,ALVAREZ OCHOA, VICTOR GUILLERMO,SANTOS MURILLO, JOSEFINA,GARCOEA ARMENTA, PATRICIA,ESPINOSA ABDALA, LEOPOLDO DE JESUS
申请号：
AT06783810
公开号：
AT554773T
申请日:
2006.07.27
申请国别(地区):
AT
年份:
2012
代理人:
摘要：
The present invention generally relates to pharmaceutical industry and to drug preparer pharmaceutical industry for prevention and/or treatment of Irritable Bowel Syndrome (IBS) and characteristic symptoms such as abdominal discomfort or pain associated with changes in defecation and frequently abdominal distension, in particular. The present invention, as compared with prior-art compositions for identical purposes, has the following advantages: fewer doses of each one of the active agents, greater speed of action and fewer side effects. The composition that reflects the teachings of the present invention comprises the synergic combination of an L-type calcium-channel blocking agent with selective action on the smooth muscle fiber of the gastrointestinal tract and an antiflatulence agent, and also pharmaceutically acceptable excipients.
